Works matching DE "OLIGODENDROGLIOMAS"

Results: 671
    1

    Diffuse gliomas: insights into clinical and histopathological features and survival rates from two centers in a middle-income country.

    Published in:
    Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1529456
    By:
    • Ordóñez-Rubiano, Edgar G.;
    • Siabato, Cristian;
    • Rincón-Arias, Nicolás;
    • Pulido, Paula A.;
    • Pimienta-Redondo, Hebert D.;
    • Espinosa-Gaona, Sebastián;
    • Useche-Diosa, Santiago;
    • Moreno, María Andrea;
    • Cifuentes-Lobelo, Hernando A.;
    • Zorro-Guio, Oscar F.;
    • Patiño-Gómez, Javier G.;
    • Cómbita, Alba Lucía;
    • Payán-Gómez, César;
    • Gutierrez-Castañeda, Luz D.;
    • Ramos-Márquez, Alexandra;
    • Gómez, Diego F.;
    • Mendoza, Oscar;
    • Baldoncini, Matias;
    • Parra-Medina, Rafael
    Publication type:
    Article
    2
    3

    Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 149, n. 2, p. 337, doi. 10.1007/s11060-020-03613-6
    By:
    • Tatekawa, Hiroyuki;
    • Hagiwara, Akifumi;
    • Uetani, Hiroyuki;
    • Yao, Jingwen;
    • Oughourlian, Talia C.;
    • Bahri, Shadfar;
    • Wang, Chencai;
    • Raymond, Catalina;
    • Lai, Albert;
    • Cloughesy, Timothy F.;
    • Nghiemphu, Phioanh L.;
    • Liau, Linda M.;
    • Pope, Whitney B.;
    • Salamon, Noriko;
    • Ellingson, Benjamin M.
    Publication type:
    Article
    4

    Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflow.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 149, n. 2, p. 305, doi. 10.1007/s11060-020-03605-6
    By:
    • Tseng, Chia-Lin;
    • Stewart, James;
    • Whitfield, Gillian;
    • Verhoeff, Joost J. C.;
    • Bovi, Joseph;
    • Soliman, Hany;
    • Chung, Caroline;
    • Myrehaug, Sten;
    • Campbell, Mikki;
    • Atenafu, Eshetu G.;
    • Heyn, Chinthaka;
    • Das, Sunit;
    • Perry, James;
    • Ruschin, Mark;
    • Sahgal, Arjun
    Publication type:
    Article
    5
    6
    7
    8

    Long-term survival outcomes of pineal region gliomas.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 148, n. 3, p. 651, doi. 10.1007/s11060-020-03571-z
    By:
    • Choque-Velasquez, Joham;
    • Resendiz-Nieves, Julio;
    • Jahromi, Behnam Rezai;
    • Baluszek, Szymon;
    • Muhammad, Sajjad;
    • Colasanti, Roberto;
    • Hernesniemi, Juha
    Publication type:
    Article
    9
    10
    11
    12

    Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 148, n. 1, p. 187, doi. 10.1007/s11060-020-03513-9
    By:
    • Mair, Maximilian J.;
    • Wöhrer, Adelheid;
    • Furtner, Julia;
    • Simonovska, Anika;
    • Kiesel, Barbara;
    • Oberndorfer, Stefan;
    • Ungersböck, Karl;
    • Marosi, Christine;
    • Sahm, Felix;
    • Hainfellner, Johannes A.;
    • Rössler, Karl;
    • Preusser, Matthias;
    • Widhalm, Georg;
    • Berghoff, Anna S.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    Targetable molecular alterations in congenital glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 146, n. 2, p. 247, doi. 10.1007/s11060-019-03377-8
    By:
    • Gilani, Ahmed;
    • Donson, Andrew;
    • Davies, Kurtis D.;
    • Whiteway, Susan L.;
    • Lake, Jessica;
    • DeSisto, John;
    • Hoffman, Lindsey;
    • Foreman, Nicholas K.;
    • Kleinschmidt-DeMasters, B. K.;
    • Green, Adam L.
    Publication type:
    Article
    21

    Prediction of lower-grade glioma molecular subtypes using deep learning.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 146, n. 2, p. 321, doi. 10.1007/s11060-019-03376-9
    By:
    • Matsui, Yutaka;
    • Maruyama, Takashi;
    • Nitta, Masayuki;
    • Saito, Taiichi;
    • Tsuzuki, Shunsuke;
    • Tamura, Manabu;
    • Kusuda, Kaori;
    • Fukuya, Yasukazu;
    • Asano, Hidetsugu;
    • Kawamata, Takakazu;
    • Masamune, Ken;
    • Muragaki, Yoshihiro
    Publication type:
    Article
    22
    23
    24
    25

    A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 146, n. 1, p. 79, doi. 10.1007/s11060-019-03337-2
    By:
    • van den Bent, Martin;
    • Azaro, Analia;
    • De Vos, Filip;
    • Sepulveda, Juan;
    • Yung, W. K. Alfred;
    • Wen, Patrick Y.;
    • Lassman, Andrew B.;
    • Joerger, Markus;
    • Tabatabai, Ghazaleh;
    • Rodon, Jordi;
    • Tiedt, Ralph;
    • Zhao, Sylvia;
    • Kirsilae, Tiina;
    • Cheng, Yi;
    • Vicente, Sergio;
    • Balbin, O. Alejandro;
    • Zhang, Hefei;
    • Wick, Wolfgang
    Publication type:
    Article
    26
    27

    Complementary and alternative medicine use in glioma patients in France.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 145, n. 3, p. 487, doi. 10.1007/s11060-019-03315-8
    By:
    • Le Rhun, Emilie;
    • Devos, Patrick;
    • Bourg, Véronique;
    • Darlix, Amélie;
    • Lorgis, Véronique;
    • Ahle, Guido;
    • Boone, Mathieu;
    • Taillandier, Luc;
    • Curtit, Elsa;
    • Gras, Louis;
    • Lebrun Frenay, Christine;
    • Gramatzki, Dorothee;
    • Ramirez, Carole;
    • Simon, Nicolas;
    • Weller, Michael
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    Oligodendroglioma confers higher risk of radiation necrosis.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 145, n. 2, p. 309, doi. 10.1007/s11060-019-03297-7
    By:
    • Ahmad, Haroon;
    • Martin, David;
    • Patel, Sohil H.;
    • Donahue, Joseph;
    • Lopes, Beatriz;
    • Purow, Benjamin;
    • Schiff, David;
    • Fadul, Camilo E.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39

    Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 143, n. 1, p. 107, doi. 10.1007/s11060-019-03140-z
    By:
    • Fleischhack, G.;
    • Massimino, M.;
    • Warmuth-Metz, M.;
    • Khuhlaeva, E.;
    • Janssen, G.;
    • Graf, N.;
    • Rutkowski, S.;
    • Beilken, A.;
    • Schmid, I.;
    • Biassoni, V.;
    • Gorelishev, S. K.;
    • Kramm, C.;
    • Reinhard, H.;
    • Schlegel, P. G.;
    • Kortmann, R.-D.;
    • Reuter, D.;
    • Bach, F.;
    • Iznaga-Escobar, N. E.;
    • Bode, U.
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46

    International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 141, n. 2, p. 253, doi. 10.1007/s11060-018-03038-2
    By:
    • Tsoli, Maria;
    • Shen, Han;
    • Mayoh, Chelsea;
    • Franshaw, Laura;
    • Ehteda, Anahid;
    • Upton, Danielle;
    • Carvalho, Diana;
    • Vinci, Maria;
    • Meel, Michael H.;
    • van Vuurden, Dannis;
    • Plessier, Alexander;
    • Castel, David;
    • Drissi, Rachid;
    • Farrell, Michael;
    • Cryan, Jane;
    • Crimmins, Darach;
    • Caird, John;
    • Pears, Jane;
    • Francis, Stephanie;
    • Ludlow, Louise E. A.
    Publication type:
    Article
    47
    48
    49
    50